The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2017

Filed:

Mar. 04, 2014
Applicant:

The Trustees of Columbia University IN the City of New York, New York, NY (US);

Inventors:

Ira Tabas, New City, NY (US);

Lale Ozcan, Edgewater, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/00 (2006.01); C12N 9/99 (2006.01); C07K 16/40 (2006.01); A01K 67/027 (2006.01); C07K 14/705 (2006.01); C12N 9/12 (2006.01); A61K 31/47 (2006.01); A61K 31/472 (2006.01); C12N 15/113 (2010.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); A01K 67/0275 (2013.01); A61K 31/47 (2013.01); A61K 31/472 (2013.01); C07K 14/705 (2013.01); C12N 9/1205 (2013.01); C12N 15/1137 (2013.01); G01N 33/5023 (2013.01); A01K 2207/05 (2013.01); A01K 2207/25 (2013.01); A01K 2217/075 (2013.01); A01K 2217/15 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0362 (2013.01); G01N 2333/91215 (2013.01); G01N 2500/10 (2013.01); G01N 2800/04 (2013.01);
Abstract

The present invention relates to methods of treating or preventing a metabolic disorder in a subject, methods of treating or preventing coronary artery disease in a subject with a metabolic disorder, as well as methods of reducing hepatic glucose production in a subject. Such methods include, but are not limited to, the administration to the subject of inhibitors or activators of CaMKII, IP3Rs, calcineurin, p38, MK2/3, HDAC4, Dach1, Dach2, or any combination thereof. The invention also provides methods of identifying a compound that inhibits the activity of CaMKII, IP3Rs, calcineurin, p38, MK2/3, HDAC4, Dach1 or Dach2, or reduces the activity and/or activation of CaMKII, IP3Rs, calcineurin, p38, MK2/3, HDAC4, Dach1 or Dach, or activates CaMKII, IP3Rs, calcineurin, p38, MK2/3, HDAC4, Dach1 or Dach2.


Find Patent Forward Citations

Loading…